Dr. Chrystal Yin Chang, MD

Dr. Chang practices at Rutgers Cancer Institute of New Jersey in Tinton Falls, New Jersey.

Dr. Chang's NPI, 1568995009, was assigned on April 11, 2017. Dr. Chang graduated from Rutgers New Jersey Medical School in 2017. Dr. Chang holds Pennsylvania license MD477520.

Dr. Chang's primary practice is Rutgers Cancer Institute of New Jersey, at 66 Gilbert W St, Tinton Falls, NJ 07701 in Monmouth County. The practice phone is (732) 235-2465.

Dr. Chang's primary practice is Rutgers Cancer Institute of New Jersey in Tinton Falls, New Jersey. Dr. Chang is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Rutgers Robert Wood Johnson Medical Group. Dmand AI also links Dr. Chang to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chang is licensed in Pennsylvania.

CMS data shows 280 Medicare services from Dr. Chang across 9 procedure codes in 2024, for 129 Medicare patients. Medicare paid $32,172 for them.

CMS counts 129 Medicare patients who saw Dr. Chang in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 67, with 15% women.

In 2024, Dr. Chang wrote 323 Medicare Part D claims for 102 patients. 95% of them were for generic drugs. CMS names the drug for 223 of them, across 7 drugs with 11 or more claims each, at $4,164 in total drug cost. In 2023, CMS named 71 claims across 3 drugs.

Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth. CMS counts 17 procedures of melanoma (skin cancer) excision by Dr. Chang, more than 72% of the clinicians it reports for that procedure.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Chang, published from 2017 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Penile Implantation, Penile Prosthesis and Erectile Dysfunction. Dr. Chang has published most often in Urology. Dr. Chang's most frequent co-authors are Jay Simhan, MD, Martin Simon Gross, MD and Moneer K. Hanna, MD.

CMS Open Payments shows 38 general payments to Dr. Chang from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Coloplast Corp paid the most, $944.

Dr. Chang graduated from Rutgers New Jersey Medical School in 2017.